Phillips Anne M. 4
4 · Sagimet Biosciences Inc. · Filed Aug 5, 2024
Insider Transaction Report
Form 4
Phillips Anne M.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-01+113,895→ 113,895 totalExercise: $3.48Exp: 2034-07-31→ Series A Common Stock (113,895 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable over thirty-six (36) equal monthly installments following August 1, 2024, subject to the Reporting Person's continued service on each such vesting date.